Macrophage colony-stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro
- PMID: 2016569
- DOI: 10.1002/jlb.49.5.483
Macrophage colony-stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro
Abstract
Functional competence as well as phenotype heterogeneity of macrophages depend on the completion of their maturation pathway. Differentiation of committed myeloid progenitor cells is induced by colony-stimulating factors (CSF), but no consistent data exist on which factor(s) induce the terminal maturation from the circulating blood monocyte to the mature macrophage. In vitro, monocyte to macrophage transformation occurs in the presence of serum and can be followed by the expression of the maturation-associated antigens gp65-MAX.1, gp68-MAX.3, and CD51. We describe that the differentiation-inducing activity in serum cannot be replaced by any of the known and available purified recombinant cytokines. In the absence of serum monocytes die in suspension cultures while surviving as non-differentiating cells when cultured adherent to plastic. In serum-free suspension cultures survival can be significantly improved by the addition of recombinant human macrophage (rhM)-CSF whereas other cytokines do not. At any stage of serum-free adherent culture, monocyte to macrophage differentiation can be induced rapidly by the addition of serum, whereas cytokines (rhM-CSF, recombinant human granulocyte macrophage [rhGM]-CSF, recombinant human granulocyte [rhG]-CSF, recombinant human interleukin [rhIL]-1, rhIL-3, rhIL-4, rhIL-6, tumor necrosis factor [TNF]-alpha, interferon [IFN]-alpha, IFN-gamma) alone or in combination are not effective. Serum-induced maturation, however, was suppressed in the presence of neutralizing anti-M-CSF antibodies. In addition to phenotype analysis, the secretory repertoire of rhM-CSF cultured monocytes was analyzed in comparison to serum cultured monocytes which further characterized them to be immature cells, i.e., low release of maturation-associated products such as alpha-2-macroglobulin, neopterin, fibronectin, and TNF-alpha, but high IL-6 secretion, an attribute of blood monocytes. We conclude that for monocyte survival in vitro the presence of endogenous M-CSF and possibly other autocrine factors elicited by cell adherence are required for the induction of macrophage maturation; however, yet undefined additional factor(s) are necessary. They are present in serum and may act in conjunction with M-CSF but are distinct from all known cytokines. Our in vitro system may be useful in the screening and discovery of these serum factor(s).
Similar articles
-
Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.Am J Hematol. 2004 Apr;75(4):179-89. doi: 10.1002/ajh.20010. Am J Hematol. 2004. PMID: 15054806
-
Surface phenotype analysis of human monocyte to macrophage maturation.J Leukoc Biol. 1990 Jun;47(6):490-7. doi: 10.1002/jlb.47.6.490. J Leukoc Biol. 1990. PMID: 1693647
-
Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.Blood. 1997 Feb 15;89(4):1147-53. Blood. 1997. PMID: 9028936
-
Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages.Int J Hematol. 2002 Jul;76(1):27-34. doi: 10.1007/BF02982715. Int J Hematol. 2002. PMID: 12138892 Review.
-
The effects of rhGM-CSF on macrophage function.Eur J Cancer. 1993;29A Suppl 3:S10-3. doi: 10.1016/0959-8049(93)90625-p. Eur J Cancer. 1993. PMID: 8398363 Review.
Cited by
-
Macrophage variants in laboratory research: most are well done, but some are RAW.Front Cell Infect Microbiol. 2024 Oct 9;14:1457323. doi: 10.3389/fcimb.2024.1457323. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39445217 Free PMC article. Review.
-
Generation of macrophages from peripheral blood monocytes in the rhesus monkey.J Immunol Methods. 2009 Dec 31;351(1-2):36-40. doi: 10.1016/j.jim.2009.09.013. Epub 2009 Oct 8. J Immunol Methods. 2009. PMID: 19818793 Free PMC article.
-
Induced Pluripotent Stem Cell-Derived Monocytes/Macrophages in Autoinflammatory Diseases.Front Immunol. 2022 May 6;13:870535. doi: 10.3389/fimmu.2022.870535. eCollection 2022. Front Immunol. 2022. PMID: 35603217 Free PMC article. Review.
-
Human pluripotent stem cell-derived macrophages and macrophage-derived exosomes: therapeutic potential in pulmonary fibrosis.Stem Cell Res Ther. 2022 Sep 2;13(1):433. doi: 10.1186/s13287-022-03136-z. Stem Cell Res Ther. 2022. PMID: 36056418 Free PMC article. Review.
-
An autologous ex vivo model for exploring patient-specific responses to viro-immunotherapy in glioblastoma.Cell Rep Methods. 2024 Mar 25;4(3):100716. doi: 10.1016/j.crmeth.2024.100716. Epub 2024 Mar 1. Cell Rep Methods. 2024. PMID: 38430913 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials